Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) today announced that James (Jim) M. Hindman has been appointed to the Company’s Board of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE